收费全文 | 595篇 |
免费 | 83篇 |
国内免费 | 54篇 |
基础医学 | 42篇 |
临床医学 | 19篇 |
内科学 | 16篇 |
皮肤病学 | 1篇 |
神经病学 | 7篇 |
特种医学 | 4篇 |
外科学 | 6篇 |
综合类 | 31篇 |
预防医学 | 7篇 |
眼科学 | 1篇 |
药学 | 539篇 |
中国医学 | 59篇 |
2023年 | 4篇 |
2022年 | 11篇 |
2021年 | 14篇 |
2020年 | 11篇 |
2019年 | 22篇 |
2018年 | 23篇 |
2017年 | 22篇 |
2016年 | 29篇 |
2015年 | 22篇 |
2014年 | 24篇 |
2013年 | 72篇 |
2012年 | 30篇 |
2011年 | 32篇 |
2010年 | 21篇 |
2009年 | 18篇 |
2008年 | 19篇 |
2007年 | 13篇 |
2006年 | 13篇 |
2005年 | 15篇 |
2004年 | 19篇 |
2003年 | 18篇 |
2002年 | 21篇 |
2001年 | 13篇 |
2000年 | 18篇 |
1999年 | 16篇 |
1998年 | 12篇 |
1997年 | 25篇 |
1996年 | 11篇 |
1995年 | 17篇 |
1994年 | 6篇 |
1993年 | 5篇 |
1992年 | 11篇 |
1991年 | 7篇 |
1990年 | 8篇 |
1989年 | 8篇 |
1988年 | 4篇 |
1987年 | 6篇 |
1986年 | 6篇 |
1985年 | 11篇 |
1984年 | 9篇 |
1983年 | 5篇 |
1982年 | 6篇 |
1981年 | 4篇 |
1980年 | 7篇 |
1978年 | 9篇 |
1977年 | 16篇 |
1976年 | 10篇 |
1975年 | 3篇 |
1974年 | 2篇 |
1971年 | 2篇 |
The metabolism of the pyrethroids deltamethrin (DLM), cis-permethrin (CPM) and trans-permethrin (TPM) was studied in human expressed cytochrome P450 (CYP) and carboxylesterase (CES) enzymes.
DLM, CPM and TPM were metabolised by human CYP2B6 and CYP2C19, with the highest apparent intrinsic clearance (CLint) values for pyrethroid metabolism being observed with CYP2C19. Other CYP enzymes contributing to the metabolism of one or more of the three pyrethroids were CYP1A2, CYP2C8, CYP2C9*1, CYP2D6*1, CYP3A4 and CYP3A5. None of the pyrethroids were metabolised by CYP2A6, CYP2E1, CYP3A7 or CYP4A11.
DLM, CPM and TPM were metabolised by both human CES1 and CES2 enzymes.
Apparent CLint values for pyrethroid metabolism by CYP and CES enzymes were scaled to per gram of adult human liver using abundance values for microsomal CYP enzymes and for CES enzymes in liver microsomes and cytosol. TPM had the highest and CPM the lowest apparent CLint values for total metabolism (CYP and CES enzymes) per gram of adult human liver.
Due to their higher abundance, all three pyrethroids were extensively metabolised by CES enzymes in adult human liver, with CYP enzymes only accounting for 2%, 10% and 1% of total metabolism for DLM, CPM and TPM, respectively.
Methods The kinetics of formation of N- and O -demethylated metabolites, nordihydrocodeine and dihydromorphine, were determined using microsomes from six extensive and one poor metabolizer and the effects of chemical inhibitors selective for individual P-450 enzymes of the 1A, 2A, 2C, 2D, 2E and 3A families and of LKM1 (anti-CYP2D6) antibodies were studied.
Results Nordihydrocodeine was the major metabolite in both poor and extensive metabolizers. Kinetic constants for N -demethylation derived from the single enzyme Michaelis-Menten model did not differ between the two groups. Troleandomycin and erythromycin selectively inhibited N -demethylation in both extensive and poor metabolizers. The CYP3A inducer, α-naphthoflavone, increased N -demethylation rates. The kinetics of formation of dihydromorphine in both groups were best described by a single enzyme Michaelis-Menten model although inhibition studies in extensive metabolizers suggested involvement of two enzymes with similar K
Conclusions CYP2D6 is the major enzyme mediating O -demethylation of dihydrocodeine to dihydromorphine. In contrast, nordihydrocodeine formation is predominantly catalysed by CYP3A. 相似文献